Physician
Pediatric Hematology & Oncology
Dr. Janet L. Franklin, MD
|
|
Give Review
Janet Franklin practices Pediatric Hematology & Oncology. She researched medicine at Georgetown University School of Medicine. Georgetown University School of Medicine is ranked 49/84 in Research/PrimaryCare. Janet Franklin is a published doctor. She published 29 publications, including: 'Fire Management, Managed Relocation, and Land Conservation Options for Long-Lived Obligate Seeding Plants under Global Changes in Climate, Urbanization, and Fire Regime.'
Publications
- Fire Management, Managed Relocation, and Land Conservation Options for Long-Lived Obligate Seeding Plants under Global Changes in Climate, Urbanization, and Fire Regime.
- Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: A Report from the Children's Oncology Group.
- Uncertainty in assessing the impacts of global change with coupled dynamic species distribution and population models.
- Clinical Significance of CD33 Nonsynonymous Single-Nucleotide Polymorphisms in Pediatric Patients with Acute Myeloid Leukemia Treated with Gemtuzumab-Ozogamicin-Contai...
- A randomized controlled trial of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving decitabine.
- Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric/adult AML: a report from the Children's Oncology Group and SWOG.
- WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric ac...
- Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy.
- Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
- High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report f...
- Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients.
- Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
- Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's On...
- Leukemias and lymphomas: treatment and prophylaxis of the central nervous system.
- AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: A report from the...
- Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: a Children''s Oncology Group report.
- Respiratory syncytial virus infections in children with acute myeloid leukemia: a report from the Children''s Oncology Group.
- Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes.
- Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children's Oncology Group study.
- Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with advanced CD33+ acute myeloid leukemia.
- Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children''s Cancer Group Study CCG-1961.
- Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
- Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborativ...
- Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia.
- A pharmacoeconomic analysis of pegaspargase versus native Escherichia coli L-asparaginase for the treatment of children with standard-risk, acute lymphoblastic leukemi...
- A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard...
- Preponderant mitotic activity of nonleukemic cells plays an important role in failures to detect abnormal clone in childhood acute lymphoblastic leukemia.
- Obesity and outcome in pediatric acute lymphoblastic leukemia.
Schools
Georgetown University
Baylor College Of Med
Doctors Specialties
- Pediatrics
- Pediatric Hematology
- Oncology
Accepted Insurances
Education
-
Baylor College of Medicine -
Georgetown University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Robert C. Seeger, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Doris T. Waldron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carolyn L. Kipper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Genie L. Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fiona B. Wertheimer, DO |
|
|
Dr. Andrea F. Wong, DO |
|
|
Dr. Angela Zurabyan, DO |
|
|
Dr. Yong B. Chun, MD |
|
|
Dr. Laura Gancedo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen A. Feig, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher T. Denny, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Guy A. Young, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Girish Dhall, MB
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|